A rare case of membranous nephropathy associated with chronic inflammatory demyelinating polyradiculoneuropathy
Ren Fail. 2023 Dec;45(1):2209659. doi: 10.1080/0886022X.2023.2209659.NO ABSTRACTPMID:37272115 | DOI:10.1080/0886022X.2023.2209659 (Source: Renal Failure)
Source: Renal Failure - June 5, 2023 Category: Urology & Nephrology Authors: Qiong Zhang Ying Tan Lingchao Meng Rong Xu Fude Zhou Minghui Zhao Source Type: research
Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex ® 10%) in patients with chronic inflammatory demyelinating polyneuropathy
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by progressive weakness and sensory loss, often affecting patient ’s ability to walk and perform activities of daily living inde... (Source: BMC Neurology)
Source: BMC Neurology - May 26, 2023 Category: Neurology Authors: Juliane Klehmet, Bj örn Tackenberg, Judith Haas and Bernd C. Kieseier Tags: Research Source Type: research
Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study
ConclusionA heavy burden of symptoms, comorbidities, and diagnostic testing exists in patients with CIDP initiating IVIG. Characteristics of patients with CIDP initiating different IVIG products are well balanced, suggesting an absence of clinical or demographic determinants underlying IVIG selection. (Source: Neurology and Therapy)
Source: Neurology and Therapy - May 17, 2023 Category: Neurology Source Type: research
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
ConclusionThis real-world analysis of IVIG treatment patterns and treatment and safety outcomes of patients with CIDP who initiated IVIG highlights the unmet need for improved long-term management. Further research is needed to evaluate the use of functional status measures as endpoints for immunoglobulin treatment effectiveness. (Source: Neurology and Therapy)
Source: Neurology and Therapy - May 12, 2023 Category: Neurology Source Type: research
Pediatric-onset chronic inflammatory demyelinating polyneuropathy: a multicenter study
To evaluate the clinical, demographic features, and treatment modalities of pediatric-onset chronic inflammatory demyelinating polyneuropathy (CIDP) in Turkey. (Source: Pediatric Neurology)
Source: Pediatric Neurology - May 4, 2023 Category: Neurology Authors: Gamze Sar ıkaya Uzan, Atay Vural, Deniz Yüksel, Erhan Aksoy, Ülkühan Öztoprak, Mehmet Canpolat, Selcan Öztürk, Çelebi Yıldırım, Ayten Güleç, Hüseyin Per, Hakan Gümüş, Çetin Okuyaz, Meltem Çobanoğulları Direk, Mustafa Kömür, Aycan Ü Tags: Research Paper Source Type: research
Lewis-Sumner syndrome: contribution of diffusion tensor imaging in its differential diagnosis
In this study, we aimed to elucidate if DTI was able to detect the specific nerve damage in a patient with suspected LSS, and determine if DTI presented a specific pattern that could be useful in its differential diagnosis. A 38-year-old male with a right foot drop was studied. Physical examination, electrodiagnostic, and MRI studies were performed. MRI of the lower limb was acquired in a 3-T scanner and included T1-wi, T2-TSE-SPIR, and PD-TSE-SPAIR images in axial and coronal planes. Axial DTI was acquired using a single-shot EPI sequence with diffusion encoding in 32 directions. The electrodiagnostic tests suggested a de...
Source: Skeletal Radiology - April 23, 2023 Category: Radiology Source Type: research
Chronic inflammatory neuropathies and their impact on activities and participation
CONCLUSION AND KEY FINDINGS: Activity limitations and restrictions in participation are common in CIDP patients and to a lesser extent in MMN patients. Fatigue, pain and resilience independently contributed to perceived limitations in CIDP patients. Referral to rehabilitation physician is warranted, to address these limitations appropriately.PMID:37038272 | DOI:10.1111/ene.15815 (Source: Pain Physician)
Source: Pain Physician - April 11, 2023 Category: Anesthesiology Authors: H A Wonink W J Kruithof H S Goedee A Beelen Source Type: research
Chronic inflammatory neuropathies and their impact on activities and participation
CONCLUSION AND KEY FINDINGS: Activity limitations and restrictions in participation are common in CIDP patients and to a lesser extent in MMN patients. Fatigue, pain and resilience independently contributed to perceived limitations in CIDP patients. Referral to rehabilitation physician is warranted, to address these limitations appropriately.PMID:37038272 | DOI:10.1111/ene.15815 (Source: Pain Physician)
Source: Pain Physician - April 11, 2023 Category: Anesthesiology Authors: H A Wonink W J Kruithof H S Goedee A Beelen Source Type: research
Anti-Lactosylceramide antibody positive combined central peripheral demyelination emerging from long-standing juvenile-onset chronic inflammatory polyradiculoneuropathy; a report of two cases
Anti-Lactosylceramide (LacCer) antibodies are associated with neurological inflammation involving both the peripheral and central nervous system (PNS, CNS respectively), however, the documented number of cases is small. Uncertainty remains whether its positivity can identify a unique clinical entity. Here, we describe two anti-LacCer antibody positive cases, both with long histories (> 30 years) of teenage-diagnosed chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). CNS lesions including the medulla oblongata were observed for the first time in adulthood. (Source: Journal of Neuroimmunology)
Source: Journal of Neuroimmunology - April 10, 2023 Category: Allergy & Immunology Authors: Naoki Takegami, Kaori Sakuishi, Nanaka Yamaguchi-Takegami, Shuhei Egashira, Shogo Komaki, Tatsuro Mutoh, Tatsushi Toda Tags: Short Communication Source Type: research
Beneficial effects and safety of traditional Chinese medicine for chronic inflammatory demyelinating polyradiculoneuropathy: A case report and literature review
In conclusion, the case and literature demonstrated that TCM treatment might be a more effective, low-cost, and safe option for treating CIDP. Although these preliminary findings are promising, a larger sample size and higher-quality randomized clinical trials are urgently required to confirm our findings. (Source: Frontiers in Neurology)
Source: Frontiers in Neurology - April 6, 2023 Category: Neurology Source Type: research
Effect of strength training on functional outcomes and strength in patients with polyneuropathy: A scoping review
Discussion: In this scoping review we summarized research on strength training and outcomes evaluated in interventions in patients with PNP. Eight studies were included, they indicated that strength training may be beneficial for patients with PNP. However, due to low methodological strength of most studies a recommendation for patients with PNP cannot be made. Thus, the low number of studies with relatively low quality, where various functional outcomes were used, underscores the importance of future studies to evaluate the effect of strength training on relevant functional outcomes and strength in patients with PNP. (Sou...
Source: Frontiers in Physiology - April 6, 2023 Category: Physiology Source Type: research
Current clinical management of CIDP with immunoglobulins in France: An expert opinion
Rev Neurol (Paris). 2023 Apr 3:S0035-3787(23)00892-5. doi: 10.1016/j.neurol.2023.03.010. Online ahead of print.ABSTRACTTreatment strategies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) must be adapted on a case-to-case basis. Validated and reproducible tools for monitoring treatment response are required at diagnosis, when initiating treatment and throughout follow-up. A task force of French neurologists, experts in neuromuscular disease reference centers, was assembled to provide expert advice on the management of typical CIDP with intravenous immunoglobulins (Ig), and to harmonize treatment practic...
Source: Revue Neurologique - April 5, 2023 Category: Neurology Authors: P Cintas F Bouhour C Cauquil M Masingue C Tard S Sacconi E Delmont A Choumert J-B Chanson M Michaud G Sol é J Cassereau J-B Noury G Nicolas R Bellance Y P éréon J-P Camdessanch é L Magy S Attarian French Neuromuscular diseases network (Filnemus) Source Type: research
Growing Spectrum of Autoimmune Nodopathies
AbstractPurpose of ReviewRecognition of node of Ranvier as the site of injury in inflammatory neuropathies contributed to discovery of antibodies against the nodal/paranodal structures. These antibodies mediate a unique type of inflammatory neuropathies that are different from typical chronic inflammatory demyelinating polyneuropathy. This review discusses the advancements made in the field of autoimmune neuropathies secondary to antibodies to nodal and paranodal proteins.Recent FindingsNeuropathies caused by antibodies to nodal-paranodal antigens including neurofascin 186, neurofascin 155, contactin1, and contactin-associ...
Source: Current Neurology and Neuroscience Reports - April 4, 2023 Category: Neuroscience Source Type: research
Ophthalmopathy in chronic inflammatory demyelinating polyradiculoneuropathy: a case report
(Source: Acta Neurologica Belgica)
Source: Acta Neurologica Belgica - March 30, 2023 Category: Neurology Source Type: research
